Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective Effect on Coronary Microcirculation in Diabetic Patients: Ticagrelor vs Clopidogrel During PCI
2015-003621-33Phase 4Terminated
- Sponsor
- Fundación Interhospitalaria de Investigación Cardiovascular
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronary arteriosclerosis, Coronary Small Vessel Disease (CMD), type 2 diabetes mellitus (T2DM) and 1 more comparing Ticagrelor arm with Clopidogrel arm (2 arms). Primary endpoint: Change in index of microcirculatory resistance after PCI (delta IMR-Post-PCI). Started Feb 2016; status: terminated.
02
Drugs
ticagrelorclopidogrel
03
Conditions
coronary arteriosclerosisCoronary Small Vessel Disease (CMD)type 2 diabetes mellitus (T2DM)prediabetes
Beyond the preview
Go deeper on 2015-003621-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003621-33.